Fingerprint
Dive into the research topics of 'Combination of JAK2 and HSP90 inhibitors: An effective therapeutic option in drug-resistant chronic myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination of JAK2 and HSP90 inhibitors: An effective therapeutic option in drug-resistant chronic myelogenous leukemia
Sandip N. Chakraborty, Xiaohong Leng, Bastianella Perazzona, Xiaoping Sun, Yu Hsi Lin, Ralph B. Arlinghaus
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations